-
Study aim
-
Identifying the effect of intravenous lidocaine on reducing complications and unpleasant reactions in patients undergoing endoscopy with propofol-ketamine including pain reduction, reduction of nausea and vomiting, reduction of apnea frequency and hemodynamic instability, and reduction of length of stay in recovery
-
Design
-
The clinical trial with control group, double blind,Parallel group,randomised, phase 3 on 138 patients, patients with simple randomization of quadruple permutation block will be divided into two groups of intervention and control that the intervention group will receive Propofol, Ketamine and intravenous Lidocaine and the control group will receive Propofol and Ketamine.
-
Settings and conduct
-
Outpatient endoscopic candidates referred to the ahvaz imam khomeini hospital will be divided into intervention and control groups.The present study is double-blind so that patients and physicians will be unaware of the allocation of the control group and the intervention group.
-
Participants/Inclusion and exclusion criteria
-
patients between 18 to 65 years age who are candidates for endoscopy that classified as group 1 and 2 according to the American Society of Anesthesiology (ASA Class) and who do not have severe heart or lung disease, kidney or liver failure, and allergies to Propofol, Ketamine, or Lidocaine will be included in this study.
-
Intervention groups
-
Intervention group:receives 0.5 mg per kg of Propofol, 0.5 mg per kg of Ketamine and 1.5 mg per kg of intravenous Lidocaine
Control group:receives 0.5 mg per kg of Propofol and 0.5 mg per kg of Ketamine
-
Main outcome variables
-
Sedation level, Hemodynamic instability, drug use level